Get the SPI Wire

HCW Biologics Inc.

NASDAQ:HCWB
Annual Meeting

of Shareholders

MEETING DATE

11/17/2026
DEF 14A FILED
10/01/2026
PUBLISHED
10/01/2026 2:00 pm
TIME TO PUBLISH
10/03/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:HCWB· CUSIP 40423R204 · CLASS common stock · CIK 0001828673

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

1
FOR
0
AGAINST
0
WITHHOLD
1
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To approve, for purposes of Nasdaq Listing Rule 5635(d), the issuance of Common Warrants exercisable for up to 618,682 shares of the Company’s Common Stock pursuant to the Transaction Documents entered into by the Company and certain Investors in connection with the Company’s private placement financing completed on July 29, 2026.
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Stockholder approval is required to comply with Nasdaq Listing Rule 5635(d).

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

bad73812bb0c2badd84496dc41a83962e663f3c6f831a80383dde055298812c2

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates